|
EPC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.55840015839226E-10 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
4.44089209850063E-16 |
| Stage1-vs-Stage2 |
6.585400E-01 |
| Stage1-vs-Stage3 |
4.279800E-02 |
| Stage1-vs-Stage4 |
6.993000E-04 |
| Stage2-vs-Stage3 |
3.344800E-01 |
| Stage2-vs-Stage4 |
4.565800E-02 |
| Stage3-vs-Stage4 |
1.921390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.64690000004075E-06 |
| Normal-vs-Asian |
3.1014002477292E-10 |
| Caucasian-vs-AfricanAmerican |
4.206800E-01 |
| Caucasian-vs-Asian |
6.608400E-01 |
| AfricanAmerican-vs-Asian |
6.724200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31006316905768E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.473970E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.03289999999301E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.418600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.099600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.244800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.446200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.472400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.560000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.155700E-04 |
| Classical-VS-Follicular |
3.678200E-01 |
| Classical-VS-Other |
3.742200E-01 |
| Classical-VS-Normal |
1.14529496997307E-11 |
| Tall-VS-Follicular |
5.054500E-02 |
| Tall-VS-Other |
7.405800E-01 |
| Tall-VS-Normal |
1.63413726994577E-12 |
| Follicular-VS-Other |
6.459200E-01 |
| Follicular-VS-Normal |
3.68638453096537E-12 |
| Other-VS-Normal |
3.553200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
2.21045404202869E-12 |
| N0-vs-N1 |
2.780600E-01 |
|
|
